Fact checked byHeather Biele

Read more

July 17, 2024
1 min read
Save

EssilorLuxottica, Heidelberg Engineering announce acquisition agreement

Fact checked byHeather Biele
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

EssilorLuxottica has signed an agreement to acquire an 80% stake in Heidelberg Engineering, according to a joint press release.

“Heidelberg Engineering, renowned for its expertise in early detection and diagnosis, is a perfect fit for EssilorLuxottica as it will bolster our presence in the med-tech space,” Francesco Milleri, EssilorLuxottica’s chairman and CEO, and Paul du Saillant, the company’s deputy CEO, said in the release. “Heidelberg Engineering, with its commitment to research and development, rooted in excellence, shares our core values.”

handshake
A new acquisition agreement gives EssilorLuxottica a majority stake in Heidelberg Engineering. Image: Adobe Stock

According to the release, Germany-based Heidelberg Engineering has extensive technological and scientific expertise in OCT, real-time image processing and analytics, large-scale data analysis and digital surgical navigation, with a presence in more than 100 countries. The company will maintain its brand in the acquisition.

Christoph Schoess, co-founder and managing director of Heidelberg Engineering, noted in the release that the company’s future goals include enhancing image quality through higher resolution, expanding applications of imaging technologies and integrating AI solutions into its HEYEX health care IT platform.

“Our mission has always been to develop products that provide comprehensive, accurate and clinically relevant information to aid [eye care providers] in achieving better outcomes for their patients,” he said in the release. “We are delighted that EssilorLuxottica, a global leader in eye care, embraces our vision for creating a shared care system spanning from research to home monitoring.”